Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

140 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

NCT06993844

Conditions
Adnexal Diseases, Advanced Breast Cancer, Advanced Solid Tumors, +40 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

NCT06835569

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC (Colorectal Cancer), +33 more
Locations
  • Research Site Orlando, Florida, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site St Louis, Missouri, United States
View Trial Details
Recruiting

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

NCT06463665

Conditions
Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Bronchial Neoplasms, +23 more
Locations
  • Pioneer Research Center, LLC Bullhead City, Arizona, United States
  • Clermont Oncology Center Clermont, Florida, United States
  • Oncology & Hematology Associates of West Broward Coral Springs, Florida, United States
  • Helios Clinical Research Fort Lauderdale, Florida, United States
View all 15 locations
View Trial Details
Recruiting

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

NCT05297734

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +81 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
  • Beckman Research Institute of City of Hope Duarte, California, United States
  • VA Medical Center, Fresno Fresno, California, United States
View all 17 locations
View Trial Details
Recruiting

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

NCT02984761

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • VA Long Beach Healthcare System, Long Beach, CA Long Beach, California, United States
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States
  • Bay Pines VA Healthcare System, Pay Pines, FL Bay Pines, Florida, United States
  • Miami VA Healthcare System, Miami, FL Miami, Florida, United States
View all 17 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

NCT05770102

Conditions
Cancer, Colonic Diseases, Colorectal Neoplasms, +37 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT05768178

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
View all 16 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.

NCT05770544

Conditions
Brain Diseases, Brain Neoplasms, Cancer, +30 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details

Related conditions